Skip to main content
. 2020 May 31;37(6):114. doi: 10.1007/s11095-020-02816-w

Fig. 5.

Fig. 5

Functional assessment of Fc-mediated activities for ABP 710, infliximab (US) and infliximab (EU). (a) NK92 ADCC activity; (b) CDC activity; (c) ADCP activity; (d) binding to FcRn by AlphaScreen; Individual data points, the mean, and ± one standard deviation are shown.